Literature DB >> 33339425

Effect of Rosmarinic Acid and Ionizing Radiation on Glutathione in Melanoma B16F10 Cells: A Translational Opportunity.

Amparo Olivares1, Miguel Alcaraz-Saura1, Daniel Gyingiri Achel2, Miguel Alcaraz1.   

Abstract

To explain a paradoxical radiosensitizing effect of rosmarinic acid (RA) on the melanoma B16F10 cells, we analyzed the glutathione (GSH) intracellular production on this cell (traditionally considered radioresistant) in comparison with human prostate epithelial cells (PNT2) (considered to be radiosensitive). In PNT2 cells, the administration of RA increased the total GSH content during the first 3 h (p < 0.01) as well as increased the GSH/ oxidized glutathione (GSSG) ratio in all irradiated cultures during all periods studied (1h and 3h) (p < 0.001), portraying an increase in the radioprotective capacity. However, in B16F10 cells, administration of RA had no effect on the total intracellular GSH levels, decreasing the GSH/GSSG ratio (p < 0.01); in addition, it caused a significant reduction in the GSH/GSSG ratio in irradiated cells (p < 0.001), an expression of radioinduced cell damage. In B16F10 cells, the administration of RA possibly activates the metabolic pathway of eumelanin synthesis that would consume intracellular GSH, thereby reducing its possible use as a protector against oxidative stress. The administration of this type of substance during radiotherapy could potentially protect healthy cells for which RA is a powerful radioprotector, and at the same time, cause significant damage to melanoma cells for which it could act as a radiosensitive agent.

Entities:  

Keywords:  B16F10; PNT2; glutathione, melanoma; radiation effects; radiosensitizers

Year:  2020        PMID: 33339425     DOI: 10.3390/antiox9121291

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  5 in total

1.  Radiation-Induced Bystander Effect: Loss of Radioprotective Capacity of Rosmarinic Acid In Vivo and In Vitro.

Authors:  Amparo Olivares; Miguel Alcaraz-Saura; Daniel Gyingiri Achel; Juan de Dios Berná-Mestre; Miguel Alcaraz
Journal:  Antioxidants (Basel)       Date:  2021-02-03

Review 2.  Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling.

Authors:  Gilnei Bruno da Silva; Milena Ayumi Yamauchi; Daniela Zanini; Margarete Dulce Bagatini
Journal:  Purinergic Signal       Date:  2021-11-05       Impact factor: 3.765

3.  The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis.

Authors:  Shahin Sarowar; Davide Cirillo; Pablo Játiva; Mette Hartmark Nilsen; Sarah-Muheha Anni Otragane; Jan Heggdal; Frode Selheim; Valentín Ceña; Hans-René Bjørsvik; Per Øyvind Enger
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

Review 4.  Biomedical features and therapeutic potential of rosmarinic acid.

Authors:  Saba Noor; Taj Mohammad; Malik Abdul Rub; Ali Raza; Naved Azum; Dharmendra Kumar Yadav; Md Imtaiyaz Hassan; Abdullah M Asiri
Journal:  Arch Pharm Res       Date:  2022-04-07       Impact factor: 6.010

5.  Genoprotective Effect of Some Flavonoids against Genotoxic Damage Induced by X-rays In Vivo: Relationship between Structure and Activity.

Authors:  Miguel Alcaraz; Amparo Olivares; Daniel Gyingiri Achel; José Antonio García-Gamuz; Julián Castillo; Miguel Alcaraz-Saura
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.